Cyclic derivatives as modulators of chemokine receptor activity
US7163937B2 · kind B2 · utility
13Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2004 |
| Grant date | Jan 16, 2007 |
| Priority date | — |
| Expiry date | Sep 15, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes modulators of MCP-1 of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.